Nab-paclitaxel plus capecitabine as first-line treatment for patients with recurrence or metastatic biliary tract cancer

Zhou, J; Zong, Y; Yuan, J; Peng, Z; Lu, M; Wang, X; Shen, L

ANNALS OF ONCOLOGY, 2020; 31 (): S1315